🔗 Permalink

Inventor profile of:

Ashraf S. Ibrahim

City:

Irvine, California

Country:

United States

Published Applications:

Last publication date:

2025-08-28

Top Assignees for applications by Ashraf S. Ibrahim

The entities that hold a legal rights for patent applications filed by inventor Ibrahim Ashraf S.:

Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center 10 Torrance, CA United States
NovaDigm Therapeutics, Inc. 2 Grand Forks, ND United States
Los Angeles Biomedical Research Institute at Harbor-ULCA Medical Center 1 Torrance, CA United States
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center 1 Torrance, United States

Recent patent applications by Ibrahim Ashraf S.

Ashraf S. Ibrahim from Irvine, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-08-28

US20250268998A1

Human necessities

METHODS OF TREATMENT FOR CANDIDA AURIS INFECTIONS

#2 | 2024-06-27

US20240209070A1

Chemistry; metallurgy

COTH3 BINDING AGENTS AND USES THEREOF

#3 | 2021-02-04

US20210030852A1

Human necessities

METHODS OF TREATMENT FOR CANDIDA AURIS INFECTIONS

#4 | 2019-06-27

US20190194301A1

Chemistry; metallurgy

IMMUNOTHERAPY AND DIAGNOSIS OF MUCORMYCOSIS USING COTH

#5 | 2019-01-31

US20190030141A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING FUNGAL AND BACTERIAL PATHOGENS

#6 | 2017-06-22

US20170173153A1

Human necessities

PHARMACEUTICAL COMPOSITIONS AND METHODS TO VACCINATE AGAINST CANDIDIASIS

#7 | 2016-08-04

US20160220648A1

Human necessities

Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents

#8 | 2016-06-09

US20160159887A1

Chemistry; metallurgy

IMMUNOTHERAPY AND DIAGNOSIS OF MUCORMYCOSIS USING COTH

#9 | 2016-05-12

US20160130330A1

Chemistry; metallurgy

MAMMALIAN RECEPTORS AS TARGETS FOR ANTIBODY AND ACTIVE VACCINATION THERAPY AGAINST MOLD INFECTIONS

#10 | 2016-02-04

US20160030534A1

Human necessities

Compositions and methods for treating fungal and bacterial pathogens

#11 | 2016-02-04

US20160030533A1

Human necessities

COMPOSITIONS AND METHODS OF TREATING FUNGAL AND BACTERIAL PATHOGENS

#12 | 2015-10-01

US20150273031A1

Human necessities

Methods and compositions for vaccinating against

#13 | 2015-07-09

US20150191514A1

Chemistry; metallurgy

HYR1-derived compositions and methods of treatment using same

#14 | 2014-11-13

US20140335114A1

Chemistry; metallurgy

HYR1 AS A TARGET FOR ACTIVE AND PASSIVE IMMUNIZATION AGAINST CANDIDA

#15 | 2014-05-08

US20140127243A1

Chemistry; metallurgy

Pharmaceutical compositions and methods to vaccinate against candidiasis

#16 | 2014-05-08

US20140127218A1

Chemistry; metallurgy

PHARMACEUTICAL COMPOSITIONS AND METHODS TO VACCINATE AGAINST CANDIDIASIS

#17 | 2014-05-08

US20140127217A1

Chemistry; metallurgy

PHARMACEUTICAL COMPOSITIONS AND METHODS TO VACCINATE AGAINST CANDIDIASIS

#18 | 2014-04-24

US20140112941A1

Human necessities

Mammalian receptors as targets for antibody and active vaccination therapy against mold infections

#19 | 2014-02-06

US20140037689A1

Human necessities

PHARMACEUTICAL COMPOSITIONS AND METHODS TO VACCINATE AGAINST DISSEMINATED CANDIDIASIS AND OTHER INFECTIOUS AGENTS

#20 | 2013-05-02

US20130108642A1

Chemistry; metallurgy

Immunotherapy and diagnosis of mucormycosis using CotH

#21 | 2012-07-05

US20120171175A1

Chemistry; metallurgy

Methods for treating refractory infections in neutropenic individuals

#22 | 2012-04-19

US20120093828A1

Chemistry; metallurgy

VACCINE COMPOSITIONS AND METHODS FOR TREATMENT OF MUCORMYCOSIS AND OTHER FUNGAL DISEASES

#23 | 2011-03-10

US20110059111A1

Chemistry; metallurgy

MAMMALIAN RECEPTORS AS TARGETS FOR ANTIBODY AND ACTIVE VACCINATION THERAPY AGAINST MOLD INFECTIONS

#24 | 2010-11-11

US20100285024A1

Chemistry; metallurgy

Vaccine compositions and methods for treatment of mucormycosis and other fungal diseases

InventorID:

221976 ⎘